SBIR/STTR Research Award
SUBSTANCE P-SPECIFIC CONDUCTING POLYMER ELECTRODE
Award amount
$99,793Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Fractal Systems, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION: Neuroactive peptides are the key players in a variety of human
responses to pain, stress, hemorrhage, transfusion, orthostasis and anoxia, and
are affecting the immune system The concentration of a specific neuropeptide in
a certain system of the body can provide us with critical information on the
state of health or disease. At present, there are no neuropeptide-specific
electrodes available.
We propose to develop an electrode for specific sensing of Substance P, a
neuropeptide involved in the endogenous pain control in the central nervous
system. We will be utilizing a novel approach of electrochemical registration
of the conductivity changes, occurring in specifically designed conductive
polymer matrix upon cooperative interaction of the immobilized on the matrix
antibodies with selected neuropeptide. Specificity of such electrode can be
designed by choosing the specificity of immobilized antibody. Phase I will be
dedicated to the development and calibration of Substance P specific electrode
in vitro. Phase I will be dedicated to miniaturization of the electrode and in
vivo applications. An array of such electrodes with designed specificity will
be able to detect several peptide neurotransmitters from the same site.
PROPOSED COMMERCIAL APPLICATION:
Electrodes, developed based on our approach, will represent a significant advance
in the detection of peptide neurotransmitters, and will be a far better alternative to
the immunoassays, which are currently used. Using an array of such electrodes
with different specificity, it will be possible to detect several peptide neurotransmitters
in vivo and from the same site, which will allow to study the interactive actions of
neuropeptides on the neuroendocrine system.
Technology keywords
Not reported